Page 27 - Read Online

Tran et al. J Cancer Metastasis Treat 2020;6:47 I http://dx.doi.org/10.20517/2394-4722.2020.104 Page 11 of 11

17. Mashiko D, Young SAM, Muto M, et al. Feasibility for a large scale mouse mutagenesis by injecting CRISPR/Cas plasmid into zygotes.
Dev Growth Differ 2014;56:122-9.
18. Abràmoff MD, Magalhães PJ, Ram SJ. Image processing with imagej second edition. Biophotonics. 2004;11:36-42
19. Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide
expression profiles. Proc Natl Acad Sci U S A 2005;102:15545-50.
20. Kanehisa M. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res 2000;28:27-30.
21. Zeidman I. The fate of circulating tumors cells. I. Passage of cells through capillaries. Cancer Res 1961;21:38-9.
22. Weiss L, Harlos JP, Elkin G. Mechanism of mechanical trauma to ehrlich ascites tumor cells in vitro and its relationship to rapid
intravascular death during metastasis. Int J Cancer 1989;44:143-8.
23. Furlow PW, Zhang S, Soong TD, et al. Mechanosensitive pannexin-1 channels mediate microvascular metastatic cell survival. Nat Cell
Biol 2015;17:943-52.
24. Díaz-Montero CM, Wygant JN, McIntyre BW. PI3-K/Akt-mediated anoikis resistance of human osteosarcoma cells requires Src
activation. Eur J Cancer 2006;42:1491-500.
25. Enomoto M, Hayakawa S, Itsukushima S, et al. Autonomous regulation of osteosarcoma cell invasiveness by Wnt5a/Ror2 signaling.
Oncogene 2009;28:3197-208.
26. O’Connell MP, Fiori JL, Xu M, et al. The orphan tyrosine kinase receptor, ROR2, mediates Wnt5A signaling in metastatic melanoma.
Oncogene 2010;29:34-44.
27. Leong HS, Robertson AE, Stoletov K, et al. Invadopodia are required for cancer cell extravasation and are a therapeutic target for
metastasis. Cell Rep 2014;8:1558-70.
28. Nomachi A, Nishita M, Inaba D, Enomoto M, Hamasaki M, Minami Y. Receptor tyrosine kinase Ror2 mediates Wnt5a-induced polarized
cell migration by activating c-Jun N-terminal kinase via actin-binding protein Filamin A. J Biol Chem 2008;283:27973-81.
29. Henry CE, Llamosas E, Djordjevic A, Hacker NF, Ford CE. Migration and invasion is inhibited by silencing ROR1 and ROR2 in
chemoresistant ovarian cancer. Oncogenesis 2016;5:e226.
30. Nishita M, Park SY, Nishio T, et al. Ror2 signaling regulates Golgi structure and transport through IFT20 for tumor invasiveness. Sci Rep
2017;7:1-15.
31. Dai B, Yan T, Zhang AL. ROR2 receptor promotes the migration of osteosarcoma cells in response to Wnt5a. Cancer Cell Int 2017;17:1-9.
32. Li ZJ, Ramalingam S, Yan S, Thiele CJ. Abstract 4342: the allosteric Akt inhibitor MK-2206 inhibits neuroblastoma tumor cell growth in
vitro and in vivo. Cancer Res 2011;71:4342.
33. Hofmann C, Obermeier F, Artinger M, et al. Cell-cell contacts prevent anoikis in primary human colonic epithelial cells. Gastroenterology
2007;132:587-600.